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The present study aimed to determine whether neonatal treatment with fentanyl has lasting eﬀects on stressed developing brain.
Six-day-old rats were assigned to one of three groups (10 males/group): (1) fentanyl (incision+fentanyl), (2) saline (incision+0.9%
saline), and (3) unoperated (unoperated sham). Pups with a plantar paw incision received repetitive subcutaneous injections
of fentanyl or vehicle through postnatal days (PNDs) 6 to 8. A nonoperated sham group served as nonstressed control. Studies
included assessment of development from PND 6 to PND 21 (growth indices and behavioral testing). Fentanyl administered twice
daily for three days after surgical incision had no impact on early growth and development, as measured on PND 9, but showed a
lastingimpactonlatergrowth,enhancedbehavioraldevelopment,andloweranxiety,asmeasuredthroughPNDs10–21.Whilethis
does not completely support a beneﬁt from such treatment, our ﬁndings may contribute to support the neonatal use of fentanyl,
when indicated, even in premature newborns.
1.Introduction
Fentanyl, a potent μ-opioid agonist, is a synthetic drug that
has been widely used for pain management [1, 2]a n da sa
general anesthetic for surgical procedures in pediatrics [3–
5], namely in surgical neonatal intensive care units. In a
previous study, fentanyl was identiﬁed as being within the
5 medications with the highest exposure rates in a pediatric
intensive care unit [2].
Fentanyl is an appropriate medication that has rarely
been linked to signiﬁcant adverse eﬀects on the central ner-
voussystem(CNS)orothersystems,withpropermonitoring
[6]. However, concerning fentanyl use in pediatric critical
care population, this is one of the many medications which
are not properly tested for pediatric use [2].
It is well documented in clinics [7] and in experimental
work [8, 9] that gradual increases of standard doses of fen-
tanyl[7],illicitfentanylabuse[10],druginteractions[11],or
individualsusceptibilitymayleadtosevereneurotoxicityand
death [10]. Animal studies have also reported adverse eﬀects.
Kofke et al. [8] evaluated the neuropathological eﬀects of
fentanyl in the brain and showed that it produces limbic
system brain damage in rats and that the damage occurs
over a broad range of doses. In another study, regarding
fentanyl eﬀects in rat brain ischemia, Kofke et al. [9] showed
that fentanyl, in both high and low doses, can exacerbate
incomplete forebrain ischemia in rats. Additionally, it is
well known from the literature that large-dose opioids in
rats produce hippocampal hypermetabolism, epileptiform
activity, and neuropathologic lesions [12]. These doses in
rats are comparable in potency to a large-dose regimen that
m i g h tb eu s e di nh u m a n s[ 12].
The neonatal period is a time of rapid growth and
development of the brain, and perturbations to the normal
series of developmental events during this time can lead to
adverse functional consequences that manifest later in life.
Lack of data on the impact of fentanyl’s repeated use during
this vulnerable period of brain development raises special
concern, as is well known that the developing CNS of the
neonate is recognized as very sensitive to most anesthetics,
in animal research studies.
Our study’s primary goal was to further investigate
the possibility that repeated administration of this opiate,2 Anesthesiology Research and Practice
in a window of developmental susceptibility, could have
lasting impact on neurodevelopment. It was hypothesized
that neonate rat pups, exposed to both postoperative and
repetitive parenteral fentanyl, would show growth restric-
tion and abnormal neurobehavioral functions. As postnatal
growth and development are sensitive measures of central
neurotoxicity and brain maturation, we assessed growth and
development in the infant male rat after exposing a neonate
rat model of postoperative pain to repeated administration
of subcutaneous fentanyl during early postnatal life.
2.MaterialsandMethods
2.1. Ethics Statement. Animal protocols for this study were
writteninstrictaccordancewiththerecommendationsinthe
European legislation and meet the standards of the National
Institutes of Health, as set forth in the Guide for the Care
and Use of Laboratory Animals [13]. These protocols were
approved in advance by the Ethics Committee of the Faculty
of Medicine of the University of Coimbra.
2.2. Subjects. For this experiment, the progeny (∼12 per
litter) of 9 multiparous Wistar rats (Charles River Labora-
tories, L’Arbresle Cedex, France) was used. Litters (3 per
group) were assigned to the following groups: (1) fentanyl
(incision+fentanyl, n=10 males), (2) saline (incision +
0.9% saline control, n=10 males), and (3) unoperated
(unoperated sham control, n=10 males). Lactating dams
were maintained with their litters for 21 days, housed in
polypropylene cages in a temperature-controlled environ-
ment (20–22◦C) with a 12-hour light dark cycle and ad
libitum access to water and pelleted rat chow.
2.3. Procedures. Figure 1 summarizes study tests and proce-
dures timeframe.
Each litter was transferred together with the dam to a
clean cage with fresh bedding on postnatal day 6 (PND
6). After baseline testing and weighing, rat pups received
subcutaneously in the neck either the ﬁrst dose of fentanyl
(B|Braun Medical Lda. Barcarena, Portugal), 25 μgp e rk g
body weight (0.1mL per g weight of solution of fentanyl
dilutedto0.25μg/mLin0.9%salinesolution),or0.9%saline
solution, 0.1mL per g body weight; this was immediately
followed by creation of a deep plantar paw incision, as
previously described [14]. Brieﬂy, the plantar aspect of the
right hindpaw was prepared in a sterile manner with a 10%
povidone-iodine solution. Using a no. 11 surgical blade we
performed a midline incision from the heel to the base
of the toes under local anesthetic (ethyl chloride spray).
The underlying ﬂexor muscle was elevated and incised
longitudinally. The skin incision was closed with nylon
sutures (6/0). Equivalent subcutaneous doses of fentanyl, or
0.9% saline, were repeatedly given 8–12 hours apart from the
ﬁrst dose for three consecutive days, with a total of 6 doses
(average total dose per animal: 135μg/kg weight).
Any incidence of adverse eﬀects (namely, respiratory
depression) was recorded. Control sham animals underwent
local anesthesia with skin preparation, but no incision.
On PND 9, at least eight hours after the last injection,
assessment of growth and development was performed.
Growth and physical development, such as teething, number
of eyes open, was monitored daily through PND 6–21. The
number of eyes open was scored; the observations for each
item were coded as 0 (both eyes closed), 1 (1 eye open), and
2( b o t he y e so p e n ) .
Rats were assessed for motor and cognitive performance
between postnatal days 18 and 21 through behavioral studies
in the open-ﬁeld, elevated plus maze, wire hanging maneu-
ver, novel object recognition test of short-term memory
and accelerating rotarod. Between test phases and animals,
apparatus, and objects were thoroughly cleansed with 70%
ethanol. Behavior experiments were recorded using a camera
mounted above the testing apparatus and data were reviewed
without knowledge of each rats’ group.
Although every litter contained pups of both sexes,
growth and behavioral results reported here include data
collected only from males (10 per group).
Anesthetized rats were killed on PND 21.
2.4. Early Outcome Assessment (Acute Eﬀects of
Fentanyl Exposure)
2.4.1. Righting Reﬂex. This test took place on PND 6
(baseline information) and PND 9. It consists in the time in
seconds required for a pup placed on its back to right itself
(all 4 paws ﬂat on the surface). The amount of time required
for the pup to right itself on all 4 limbs was measured
using a stopwatch, with a maximum of 30 seconds. This
test, performed as previously described, assesses subcortical
maturation [15].
2.4.2. Negative Geotaxis. This test took place on PND 6
(baseline information) and PND 9. It consists on the time in
secondsrequiredforapupplacedheaddownona25◦ incline
toturn180◦ andbegincrawlinguptheslope.Thecutoﬀtime
was 60sec. The time spent for a turn of 180◦ upward was
recorded using a stopwatch. If unsuccessful, each pup was
given up to 3 trials. Each failed trial was recorded as value
61. Negative geotaxis, performed as previously described,
is believed to test reﬂex development, motor skills and
vestibular labyrinth, and cerebellar integration [15].
2.4.3. Locomotor Activity. This test took place on PND 6
(baseline information) and on PND 9, at least eight hours
after the last fentanyl injection. Rat pups were individually
placed in a circular hole (6cm diameter/2cm height), and
locomotor activity was scored during 3min as follows: 1:
immobility and head down; 2: raises head up; 3: forepaws
over borders; 4: climbs the borders.
2.5. Later Outcomes Assessment
2.5.1. Behavior in the Open-Field Arena. This test took place
onPND18andwasusedwiththeaimofassessinglocomotor
activity. The test was performed as previously described
[16], with slight modiﬁcations. Brieﬂy, rats were placedAnesthesiology Research and Practice 3
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Figure 1: Study tests and procedures timeframe. PhDev: growth and physical development assessment (PND 6–21); EoutBase: baseline
testing (righting reﬂex, negative geotaxis, and locomotor activity) (PND 6); EOut: early outcome assessment (PND 9); Adm: administration
procedure, according to group (administration of fentanyl, administration of 0.9% saline solution, or manipulation) (PND 6–8); Incis:
incision or manipulation, according to group (PND 6); WirePr: wire hanging maneuver pretest (PND 17); Wire: wire hanging maneuver test
(PND 18 + 20); RotaTr: accelerating rotarod training (pretest) (PND 17 + 19); Rota: accelerating rotarod test (PND 21); OpenF: behavior in
open-ﬁeld arena (PND 18); Maze: elevated plus maze test (PND 18); Recog: novel object recognition test of short-term memory (PND 19);
Sac: sacriﬁce (PND 21).
Table 1: Early outcomes.
Measures Groups P
Fentanyl Saline Unoperated
Weight, mean (±SD), g:
PND 6 12 (±1) 11 (±2) 11 (±2) >.05
PND 9 18 (±2) 16 (±3) 16 (±2) >.05
Righting latency, median (IQR), sec:
PND 6 2 (1-2) 2 (2-2) 2 (2-2) >.05
PND 9 1 (1–1.3) 1 (1-2) 1 (1–1.3) >.05
Geotactic latency, median (IQR), sec:
PND 6 183 (152–183) 29 (20–145) 34 (12–48) <.05∗
PND 9 19 (13–27) 23 (11–44) 22 (12–48) >.05
Locomotor activity score, median (IQR):
PND 6 1 (1-2) 2 (1–2.3) 1 (1-2) >.05
PND 9 2 (1.8–3) 3 (2-3) 3 (2.8–3) >.05
PND: postnatal day; IQR: interquartile range; P: signiﬁcance for independent samples.
Locomotor activity scores: 1: immobility and head down; 2: raises head up; 3: forepaws over borders; 4: climbs the borders.
Fentanyl versus saline (P = 0.005) and fentanil versus unoperated (P = 0.007), both ∗P<. 05.
Table 2: Later Outcomes.
Measures Groups P
Fentanyl Saline Unoperated
Weight PND 21, mean (±SD), g 43 (±3)∗§ 36 (±6)∗ 36 (±4)§
∗Fv e r s u sS=.001;
§Fv e r s u sU n<.001;
Eye opening score, PND 14, median (IQR) 2 (1-2) 1 (0–2) 0 (0–2) NS
Open ﬁeld, line crossing, mean (±SD) 68 (±23) 62 (±24) 48 (±27) NS
Latency time wire, median (IQR), sec:
PND 18 127 (20–183)∗ 183 (183-183)∗ 183 (162–183) ∗Fv e r s u sS=0.035
PND 20 25 (15–98) 75 (12–183) 76 (9–183) NS
Recognition index, mean (±SD) 0.8 (±0.3)∗ 0.6 ± (0.3)∗§ 0.8 (±0.2)§
∗Fv e r s u sS=0.045;
§Un versus S =0.025
Time (%) spent open arms, median (IQR) 18 (17–32)∗§ 7 (3–17)∗ 10 (7–16)§
∗Fv e r s u sS=0.034;
§Fv e r s u sU n=0.045
Best latency time fall rod, mean (±SD), sec 173 (±24)∗§ 123 (±73)∗ 128 (±24)§
∗Fv e r s u sS=0.022;
§Fv e r s u sU n=0.04
PND: postnatal day; IQR: interquartile range; P: signiﬁcance for independent samples: NS: nonsigniﬁcant; F: Fentanyl; S: Saline; Un: Unoperated.4 Anesthesiology Research and Practice
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Figure 2: Growth curves representing mean body weight (g)
through postnatal days (PNDs) 6–21. Fentanyl group showed
enhanced weight gain compared to controls, after PND 12.
individually in a transparent box (60 × 40 × 25cm) with the
ﬂoor divided into twelve identical areas in a dim room. Line
crossings (with all four paws placed into an adjacent area)
were recorded in a 5min period.
In addition, the presence/absence of exploratory behav-
iors such as rearing (standing on hind legs),grooming (using
paws or tongue to clean/scratch body), and corner-facing
(standing or sitting with the face directed toward the corner
of the box) was recorded.
2.5.2. Anxiety-Like Behavior. This test was performed on
PND 18 to assess anxiety-like behavior as previously
described [17], with slight modiﬁcations. Rats were placed
in an elevated plus maze which consisted of a cross-shaped
platform (height: 49.5cm) with four arms (width: 10cm;
length: 110.5cm), two of which were enclosed by walls
30.5cm high. Each rat was placed into the central area
facing an open arm and allowed to explore for 5min. The
percentage of time spent on the open arms and number of
entries into the open arms were used as measures of anxiety-
like behavior.
2.5.3. Wire Hanging Maneuver. Wire hanging maneuver
assesses neuromuscular and locomotor development [16].
This test was conducted over 3 days (maneuvers performed
on PNDs 18 and 20). Rats were allowed 1 pretest on PND 17.
Normal pups suspended by the forelimbs from a horizontal
wire supported between two platforms (15cm above the
table top) tend to support themselves with their hind limbs,
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Figure 3: Number of eyes open on postnatal day (PND) 14. The
number of eyes open was higher in the fentanyl group than in both
thesalineandunoperatedgroups(P>0.05).Valuesrepresentmean
and 95% conﬁdence interval for mean.
preventing falling andaiding in progression along the wireto
reachtheplatform[16].Aspongeatthebaseoftheapparatus
served as protection for the falling rats. Latency to reach one
of the platforms from the wire was measured and recorded in
seconds, with a cutoﬀ time of 60sec. Each unsuccessful trial
was recorded as value 61, with a maximum of 3 trials allowed
each day. Therefore, latency values may vary from 1 to 183
per test.
2.5.4. Novel Object Recognition Test of Short-Term Memory.
This test, based on the natural tendency of rodents to
investigate a novel object instead of a familiar one, was
carried out as previously described [18]. On PND 19 each
rat was allowed to move freely in an open-ﬁeld box for 3
min, as habituation, followed by an exposition trial in which
the rat was placed in the center of the box containing two
identical objects (transparent white blocks) located in two
adjacent corners. The cumulative time spent exploring each
object was recorded during a 5min period. Exploration was
deﬁned as actively touching or directly facing the object.
One hour later the rats were tested for memory using the
same procedure, except that one of the familiar objects was
replaced with a novel diﬀerent looking object. The time
of exploration of each object (tn and tf for novel and
familiar objects, resp.) was recorded for determination of the
recognition index (RI): RI = tn/(tn +tf).
2.5.5. Rotarod. This test was performed as previously de-
scribed [15], with slight modiﬁcations, to examine potential
eﬀects of fentanyl exposure on motor balance and coordina-
tion,usingtheacceleratingrotarod(RotaRodLI8200;LeticaAnesthesiology Research and Practice 5
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Figure 4: Latency times to complete the task of reaching the platform in the wire hanging maneuver on (a) postnatal day 18 and (b)
postnatal day 20. Both on PND 18 and 20, rats in the fentanyl group were faster than controls, with statistical diﬀerence to the saline group
(∗P = 0.035) on PND 18. Values represent mean and 95% conﬁdence interval for mean.
SA Scientiﬁc Instruments). The rotarod test was conducted
over 3 days and consisted of 2 pretests which took place on
PND 17 and 19 and a test performed on PND 21. In the
2 pretests, the rats underwent habituation and training, by
placement on the still rod to acclimate, followed by training
on the moving rotarod, beginning at a constant speed of 5–
10–20 revolutions per minute (rpm) on a schedule of three
5-minute trials. This training was repeated under the same
protocol on PND 19.
On PND 21 the rats were tested using the accelerating
rotarod: the apparatus was set to accelerate linearly from 4
to 40rpm over 300 seconds. The sessions consisted of three
5-minute trials. The latency to fall from the rotarod during a
300sectrialwasrecorded.Eachanimalwasgiven3trials,and
the best latency of three trials was calculated for each animal.
2.6. Statistics. Statistical analysis was performed using
SPSS statistical software package (version 17, SPSS, Inc.,
Chicago, Il). Normality of distribution was determined using
Kolmogorov-Smirnov and Shapiro-Wilk tests. Comparisons
were made using multigroup, one-way ANOVA to test for
the signiﬁcance of changes among the diﬀerent groups,
followed by the Least Signiﬁcant Diﬀerence test to compare
diﬀerences between groups. If the data were not normally
distributed,theKruskal-Wallistest(nonparametricANOVA)
was used, and, where diﬀerences were identiﬁed, pairwise
comparisons were performed using Mann-Whitney U test
with appropriate correction by Holm-Bonferroni method.
All diﬀerences were considered signiﬁcant at P<0.05.
Values are expressed as means ± standard deviation (±SD)
or as median and interquartile range (IQR): 25th and 75th
percentiles, mean and 95% conﬁdence interval for the mean
(95% Cl), or number (percentage), as appropriate.
3. Results
3.1. Early Outcomes. There were no deaths. All animals
reached PND 9. Table 1 summarizes the most relevant
outcomes.
Baseline characteristics of the groups were equivalent.
No signiﬁcant (P>0.05) intergroup diﬀerences were found
in the baseline (PND 6) body weight, locomotor activity
score, and righting reﬂex latency. However, rats in the
fentanyl group showed signiﬁcantly longer baseline geotactic
responses than saline (P = 0.005) and unoperated rats (P =
0.007).
During the early period of the experiment, from PND 6
to PND 9, all rats increased body weight in a steady manner,
showing no delay in physical development.
When compared to baseline results, outcomes of the
fentanyl, saline and unoperated groups, recorded on PND 9,
showed an improvement in all parameters, such as weight
gain, enhancement of locomotor activity score, and reduced
postural reﬂex latencies.
ComparisonofthePND9resultsbetweenfentanylgroup
and the controls did not show signiﬁcant diﬀerences (P>
0.05) on righting reﬂex latency, negative geotactic latency, or
locomotor activity score (Table 1).
3.2. Later Outcomes. Table 2 summarizes the most relevant
outcomes.6 Anesthesiology Research and Practice
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Figure 5: Object recognition test of short-term memory. Recogni-
tion index of novel object exploration is exploration time on new
object/total exploration time (RI = tn/(tn + tf)). The recognition
index (RI) of a novel object in fentanyl group was not signiﬁcantly
diﬀerent from that for the unoperated sham controls. However,
a signiﬁcant diﬀerence (∗P = 0.045) was evidenced between
the fentanyl group compared to the saline group, showing better
cognitive function for the ﬁrst group. A diﬀerence was also seen
between the controls: unoperated sham rats displayed signiﬁcantly
(§P = 0.025) better short-term memory compared to saline-treated
rats. Values are mean ± SD.
3.2.1. Developmental and Growth Indices. As expected, all
animals reached the deﬁned endpoint (PND 21).
All rats maintained weight gain throughout the study;
however, fentanyl-treated rats weighed signiﬁcantly more
than saline-treated and unoperated controls, from PND 12
to PND 21 (Figure 2). The mean weights (±SD) for fentanyl,
saline, and unoperated rats on PND 21 were 43 (±3)g, 36
(±6)g, and 36 (±4)g, respectively. Signiﬁcant diﬀerences
between fentanyl versus saline (P = 0.001) and fentanyl
versus unoperated rats (P<0.001) were seen. There was no
signiﬁcant diﬀerence between the control groups (P>0.05).
Eyes started to open from PND 14. The median number
of eyes open (scored as 0 or 1 or 2 eyes open) on this day
was higher in fentanyl (2) than in saline (1) and unoperated
groups (0), although without statistical signiﬁcance (P>
0.05) (Table 2 and Figure 3).
3.3. Behavior in the Open Field. There were no observable
intergroupdiﬀerencesonlocomotoractivityandexploratory
proﬁle. Although there was a trend for an increased mean
number of line crossings in the fentanyl group (mean
number: 68), compared to the saline (mean number: 62)
or the unoperated ones (mean number: 48), the diﬀerences
between groups were not statistically signiﬁcant (P>0.05),
as seen in Table 2. Additionally, all rats showed a similar
exploratory behavior proﬁle, characterized by immediate
beginning of locomotor activity (latency up to 20sec)
following the placement of the animal in the central area of
the open ﬁeld apparatus; they also showed similar proﬁles
in the type of exploratory activity periods (with rearing
and grooming behaviors) and preference for the corners
exploration over that of the central area.
3.3.1. Behavior during the Wire Hanging Maneuver. On PND
17 (habituation trial) all rats failed the task of platform
reaching.
The success in reaching the platform diﬀered among
groups both in PND 18 and PND 20. On PND 18, 60% of
the rats in the fentanyl group, 10% in the saline group, and
20% in the unoperated sham group successfully completed
the task of reaching the platform; these diﬀerences were
statistically signiﬁcant (data not shown). Moreover, rats in
the fentanyl group were faster than controls. The median
latency time to complete the task in fentanyl group (127sec)
was not signiﬁcantly diﬀerent from that in the unoperated
sham group (183sec); however we found a signiﬁcantly (P =
0.035) shorter median latency time in the fentanyl group
(127sec) when compared to the saline group (183sec), as
seen in Table 2 and Figure 4.
On PND 20, while 100% of the rats in the fentanyl
group completed the task successfully, only 60% in the saline
and 70% in the unoperated sham groups were successful
(data not shown). Again, median latency time to reach the
platform was shorter (P>0.05) in the fentanyl rats (25sec)
compared to saline (75sec) or unoperated ones (76sec), as
seen in Table 2 and Figure 4.
3.4. Eﬀects of Neonatal Fentanyl Exposure on Novel Object
Recognition Task of Short-Term Memory. Cognitive perfor-
mance in an object recognition task of short-term memory,
performed on PND 19, evidenced no adverse lasting impact
in preweanling rats after neonatal exposure to six doses of
fentanyl (average total dose per animal: 135μg/kg weight).
The mean recognition index (RI) of a novel object in
fentanyl group (0.79) was not signiﬁcantly diﬀerent (P>
0.05) from that for the unoperated sham controls (0.8).
However, a signiﬁcant diﬀerence (P = 0.045) was found
between the fentanyl group (0.8) compared to the saline
group (0.6), showing better cognitive function for the ﬁrst
group. A signiﬁcant diﬀerence was also seen between the
controls; unoperated sham rats displayed signiﬁcant (P =
0.025) better short-term memory (0.8) compared to saline-
treated rats (0.6), as seen in Table 2 and Figure 5.
3.5. Eﬀects of Neonatal Fentanyl Exposure on Anxiety-
Like Behavior. Fentanyl-treated rats were signiﬁcantly less
anxious than the saline-treated rats (P = 0.035) or the
unoperated ones (P = 0.043) in the elevated plus maze, as
indicated by the increase in the median percent time spent
in the open arms by the fentanyl-treated rats (18%, IQR
17–32), compared to the saline (7%, IQR 3–17) or to theAnesthesiology Research and Practice 7
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Figure 6: Performance in the elevated plus maze: (a) percent time in the open arms was signiﬁcantly increased in fentanyl rats compared to
saline rats (∗P = 0.034) or unoperated controls (§P = 0.045), suggesting that neonatal fentanyl exposure reduces some measures of anxiety-
like behavior on the elevated plus maze; (b) and (c) represent the number of open arm and the number of closed arm entries, respectively,
showing no signiﬁcant diﬀerences between groups. Values represent mean and 95% conﬁdence interval for mean.
unoperated sham controls (10%, IQR 7–16). However, there
were no signiﬁcant intergroup diﬀerences between open or
closed arm entries (Table 2 and Figure 6).
3.6.EﬀectsontheAcceleratingRotarod. Theeﬀectsoffentanyl
exposure on locomotor coordination and balance, as mea-
sured by the accelerating rotarod, are shown in Figure 7.
The best (largest) of the three fall latency values
(mean ± S D )a c h i e v e dp e rr a to nP N D2 1w a su s e df o rd a t a
analysis. Mean latency to fall from the rod for fentanyl group
was 173sec, for saline group was 123sec, and for unoperated
sham rats was 128sec. Rats treated with fentanyl spent
signiﬁcantlymoretimeonrod,comparedtoratstreatedwith
saline (P = 0.022) or unoperated sham rats (P = 0.04), as
seen in Table 2 and Figure 7.8 Anesthesiology Research and Practice
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Figure 7: Best latency time to fall from the accelerating rotarod
(speed 5–40rpm). Rats administered fentanyl spent signiﬁcantly
more time on rod, compared to rats administered saline (∗P =
0.022) or unoperated sham rats (§P = 0.040). Values are mean ±
SD.
4. Discussion
The present study was designed to assess whether exposure
to repetitive injections of fentanyl during brain development
inﬂuences later physical and neurological outcomes. Using a
neonatal postoperative pain model, this study demonstrates,
for the ﬁrst time, lasting eﬀects on growth and behavior
of rat pups that underwent repeated fentanyl exposure
during early postnatal life, when tested as later pre-weanling
rats. The results showed that repeated fentanyl exposure of
an immature stressed animal signiﬁcantly interferes with
growth, cognitive function, behavioral reactivity to stress,
neuromuscular and locomotor development, and balance
and coordination. All these outcomes (Table 2)s u g g e s t
a neurological impact with possible consequences, either
positive or negative, later in life.
To examine the role of fentanyl administration in the
development of behaviors that occur following repeated
exposure to this medication, both in immature CNS and
pain settings, we combined two strategies: the model for
the study of neonatal neurodevelopment (6-day-old rat pup)
was combined with the postincisional pain of Brennan paw
incision [14], as a model for neonatal neurodevelopmental
and postoperative pain. Translation of developmental ages
f r o mr o d e n t st oh u m a n sc o n t i n u e st ob ed e b a t e d .Ar e v i e w
paper by Vidair [19], which discusses the adequacy of the
postnatalrattoserveasamodelforneurodevelopmentinthe
postnatalhuman,concludesthattheratinthethirdpostnatal
week is the neurodevelopmental equivalent of the newborn
human and that the two species share numerous pathways
of postnatal neurodevelopment. Therefore, our neonatal
rat model roughly corresponds to a human premature.
Brennan’s model of incisional pain [14] was chosen since
it simulates the usual clinical setting involving critically ill
prematures in neonatal intensive care units.
Premature newborns typically present a broad range of
comorbidities which make them a complex group to study,
given the many variables, painful/stressful procedures, and
pharmacologic exposures involved. Therefore, experimental
studies using animals allow us to exclude potential con-
founding variables. In our study we used a model without
comorbidities in a postoperative pain and stress setting.
Such a preclinical model, which leads to pain-related events
that mirror the symptoms observed in patients undergoing
surgery [20], gives us the opportunity to explore whether
repetitive fentanyl exposure, early in neonates subject to
painfulstimuli,leadstolaterneurodevelopmentalanomalies.
The postoperative pain model we used was previously
described by Brennan and coworkers [14]. This rat model
consists of an incision of the plantar paw skin, with damage
of the underlying muscle, which results in localized mechan-
ical hypersensitivity that lasts 3–5 days. Further research by
Brennan’s group showed release of excitatory amino acids,
such as glutamate and aspartate, activation of dorsal horn
cells, and central sensitization [21].
Concerning protocol design, the dose of fentanyl used
in this study, although at ﬁrst sight much higher than the
neonatal human recommended dose, was chosen according
to the species known metabolism to relate to that typically
encountered in clinical settings reﬂecting antinociceptive
ED50 values for PND6 rats [22]. We assessed behavioral
problems in our neonatal stressed model using a validated
set of tests usually chosen for drug toxicity screening.
Among major ﬁndings in the present study, we highlight
the signiﬁcant enhancement of weight gain in fentanyl group
compared to controls, as summarized in Table 2. Neither
fentanyl nor control conditions had signiﬁcant eﬀects on
normal early pup weight gain. In contrast, there were
signiﬁcant group diﬀerences in rat weights on PND 21.
Rats in the fentanyl group weighed more than those in
the saline and unoperated sham groups, with the diﬀerence
becoming signiﬁcant around PND 12 and expanding as
the pups aged until weaning. These outcomes suggest that
the eﬀects of the early postnatal exposure were subtle
but, nonetheless, predisposed the pups to abnormal weight
gain. Many hypotheses are possible to explain this ﬁnd-
ing, namely, metabolic derangements, behavior anomalies
related to eating disorders, or decreased physical activity.
An important issue that can be raised is whether the
weight change is transitory or if it can continue into
adulthood.
Other major ﬁndings in the present study were behav-
ioral changes induced by administration of fentanyl in our
model. Somewhat surprisingly, the results point towards an
overall apparently “positive” eﬀect on neurodevelopment,
instead of the expected negative one. This “positive” impact
was evidenced by an apparent lack of signiﬁcant acute toxic
eﬀects on early development. Moreover, later, in infant rats
who were treated with fentanyl, we found enhancementAnesthesiology Research and Practice 9
of the recognition index of a novel object, lesser anxiety-
like behavior, and better performances on the wire hanging
maneuver and on the accelerating rotarod. Furthermore,
there was a trend for sooner eye opening in this group,
suggesting that the eye command center of CNS of rats in
the fentanyl group ages earlier.
Interestingly, aversive stressful procedures performed in
the current study, which should be associated with increased
anxiety, seemed blunted by fentanyl treatment. In fact,
fentanyl-treated rats were signiﬁcantly less anxious than the
salineandtheunoperatedratsintheelevatedplusmaze.This
outcome is not clearly explained, but calmer subjects can
probably better explain other outcomes found in this study,
suchasenhanced cognitive function, motor, and balanceand
coordination. It is possible that all these results are at least
partially explained by a fentanyl impact on the development
of central neuronal circuits, given the great plasticity of the
CNS characteristic of the immature mammalian brain [23].
The eﬀects of the impact of fentanyl on SNC are
probably complex and multivariate with diﬀerent possible
mechanisms found in the literature, both potentially pro-
tective or detrimental, such as faster CNS myelination and
enhanced neurogenesis by NeuroD activity level increase
(a transcription factor essential for the development of the
CNS) [24] eventually translating into enhanced performance
or, on the other hand, cytotoxic lesion/blockade of the
ventral hippocampus by N-methyl-D-aspartate (NMDA)
receptor interference, manifesting as reduced anxiety [25].
It is well known from the literature that fentanyl modulates
important cellular and molecular neuronal mechanisms,
interfering not only in anatomically distributed neural
networkinvolvedingeneratingstatesofanesthesiabutalsoin
mechanisms involved in hippocampus neurogenesis. In this
setting, fentanylmayregulatethefunctionsofthedeveloping
hippocampus, a region highly related to learning, memory,
stress responses, and emotionality [25].
There is a growing body of evidence showing that drugs
interfering in the SNC functions may cause pharmacologic
neuroprotection or, on the opposite, detrimental eﬀects,
depending on the pathological conditions [19, 26–28]. Neg-
ative impact alerts are particularly alarming in the context
of very ill preterm infants who usually present a multitude
of physiological derangements and pathological pain con-
ditions coupled with a very immature brain, therefore it is
important to deﬁne safe indications and doses for the use of
these drugs, such as fentanyl, in this stage.
In conclusion, the current study is the ﬁrst to demon-
stratethatratpupsexposedtoparenteralfentanylinapainful
context have lasting growth and behavioral changes. The
study highlights behavioral changes that could potentially
aﬀect brain function either in a positive or negative manner.
These results should serve as a basis for further research
and should lead investigators to focus on speciﬁc pathways
relevant to the changes in behavior we have shown. Our
ﬁndings may contribute to support the neonatal use of
fentanyl, when indicated, namely in postsurgical settings,
even in premature newborns. However, extrapolating our
data to a clinical setting must be done with caution, as with
every animal study.
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